NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $22.00
  • Forecasted Upside: 31.50 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$16.73
▼ -0.04 (-0.24%)

This chart shows the closing price for MDRX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Allscripts Healthcare Solutions Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDRX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDRX

Analyst Price Target is $22.00
▲ +31.50% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Allscripts Healthcare Solutions in the last 3 months. The average price target is $22.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 31.50% upside from the last price of $16.73.

This chart shows the closing price for MDRX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Allscripts Healthcare Solutions. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 4 sell ratings
11/28/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 4 sell ratings
2/26/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 3 sell ratings
5/27/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/25/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings
11/23/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
2/21/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 1 sell ratings
4/22/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/22/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2022Piper SandlerLower Price Target$22.00 ➝ $19.00High
3/18/2022Piper SandlerBoost Price TargetNeutral$19.00 ➝ $22.00High
3/4/2022Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$20.00 ➝ $26.00Medium
3/3/2022SVB LeerinkBoost Price TargetOutperform$22.00 ➝ $24.00Medium
1/25/2022SVB LeerinkUpgradeMarket Perform ➝ Outperform$19.00 ➝ $22.00High
1/25/2022Piper SandlerBoost Price Target$17.00 ➝ $19.00High
11/23/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$18.00 ➝ $20.00Low
11/5/2021Cantor FitzgeraldReiterated RatingNeutralMedium
8/6/2021Piper SandlerReiterated RatingIn-Line ➝ Neutral$15.00 ➝ $17.00Low
8/6/2021SVB LeerinkBoost Price TargetMarket Perform$17.00 ➝ $19.00High
8/6/2021Royal Bank of CanadaBoost Price TargetOutperform$17.00 ➝ $19.00High
5/26/2021SVB LeerinkBoost Price TargetMarket Perform$16.00 ➝ $17.00Medium
5/20/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$15.00 ➝ $17.00Low
4/30/2021SVB LeerinkBoost Price TargetMarket Perform$15.00 ➝ $16.00Low
4/29/2021JPMorgan Chase & Co.Initiated CoverageUnderweightLow
3/8/2021ArgusReiterated RatingBuy ➝ HoldN/A
3/2/2021ArgusDowngradeBuy ➝ HoldHigh
2/26/2021SVB LeerinkLower Price TargetMarket Perform$16.00 ➝ $15.00High
2/26/2021Piper SandlerLower Price TargetNeutral$17.00 ➝ $15.00High
2/16/2021Piper SandlerBoost Price TargetNeutral$11.50 ➝ $17.00Low
11/25/2020Bank of AmericaBoost Price TargetBuy$14.00 ➝ $16.50Low
11/11/2020ArgusUpgradeHold ➝ Buy$14.00Low
10/23/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$9.00 ➝ $11.00Low
10/19/2020Robert W. BairdDowngradeOutperform ➝ Neutral$13.00High
10/14/2020Cantor FitzgeraldBoost Price TargetNeutral$9.00 ➝ $13.00High
10/14/2020SVB LeerinkBoost Price TargetMarket Perform$10.00 ➝ $13.00High
8/24/2020JPMorgan Chase & Co.Boost Price TargetNeutral$8.00 ➝ $9.00Low
8/11/2020Morgan StanleyBoost Price TargetUnderweight$6.00 ➝ $8.00High
8/3/2020Royal Bank of CanadaBoost Price TargetOutperform$8.00 ➝ $10.00High
7/31/2020Cantor FitzgeraldBoost Price TargetHold ➝ Neutral$6.00 ➝ $9.00High
7/31/2020SVB LeerinkBoost Price TargetMarket Perform$6.00 ➝ $10.00Low
7/21/2020The Goldman Sachs GroupDowngradeNeutral ➝ Sell$6.50 ➝ $5.50High
6/11/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$11.00 ➝ $9.00High
5/13/2020Morgan StanleyBoost Price TargetUnderweight$5.00 ➝ $6.00Low
5/13/2020SunTrust BanksBoost Price TargetHold$6.00 ➝ $7.00High
5/10/2020Royal Bank of CanadaReiterated RatingBuy$8.00Low
5/8/2020SVB LeerinkLower Price TargetMarket Perform$8.00 ➝ $6.00Medium
5/8/2020Cantor FitzgeraldReiterated RatingNeutral$8.00 ➝ $6.00High
4/22/2020Jefferies Financial GroupDowngradeBuy ➝ Hold$10.50 ➝ $7.00High
4/20/2020Royal Bank of CanadaInitiated CoverageOutperform$8.00Medium
4/13/2020SVB LeerinkInitiated CoverageMarket Perform$8.00High
3/5/2020SunTrust BanksLower Price TargetHold$11.00 ➝ $9.00High
3/4/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$12.00 ➝ $11.00High
3/3/2020Dougherty & CoReiterated RatingBuyHigh
3/3/2020Piper SandlerLower Price Target$12.00 ➝ $9.50High
3/3/2020CfraLower Price TargetStrong Sell$9.00 ➝ $6.00Medium
3/3/2020Robert W. BairdLower Price TargetOutperform$13.00 ➝ $10.00High
3/3/2020Cantor FitzgeraldReiterated RatingNeutral$11.00 ➝ $8.00High
11/26/2019UBS GroupInitiated CoverageNeutral$11.50Low
11/5/2019Cantor FitzgeraldReiterated RatingNeutralMedium
9/26/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$11.00Low
8/23/2019Jefferies Financial GroupInitiated CoverageBuy$13.00High
8/12/2019Robert W. BairdSet Price TargetBuy$13.00Medium
8/11/2019Evercore ISIReiterated RatingHold$11.50Low
5/2/2019Cantor FitzgeraldReiterated RatingHold$10.00High
2/22/2019CitigroupDowngradeBuy ➝ Neutral$14.00 ➝ $12.00High
11/14/2018ArgusDowngradeBuy ➝ HoldLow
11/2/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$16.00 ➝ $14.00Low
11/2/2018CitigroupLower Price TargetBuy ➝ Buy$19.00 ➝ $17.00Low
11/2/2018Bank of AmericaLower Price TargetBuy ➝ Buy$16.50 ➝ $15.00High
11/2/2018SunTrust BanksDowngradeBuy ➝ HoldHigh
11/2/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$16.00 ➝ $12.00High
11/1/2018Cantor FitzgeraldDowngradeOverweight ➝ Neutral$12.00High
8/3/2018Royal Bank of CanadaReiterated RatingBuy$14.00High
8/2/2018Cantor FitzgeraldReiterated RatingBuy$17.00High
6/8/2018Cantor FitzgeraldReiterated RatingBuy$18.00Low
5/4/2018Bank of AmericaLower Price TargetBuy ➝ Buy$17.00 ➝ $15.50High
5/4/2018Maxim GroupReiterated RatingBuy$18.00High
5/4/2018SunTrust BanksUpgradeHold ➝ Buy$10.78 ➝ $16.13High
5/3/2018Cantor FitzgeraldReiterated RatingBuy$18.00Medium
4/24/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$16.00High
4/5/2018Cantor FitzgeraldReiterated RatingBuy$18.00Low
3/6/2018Cantor FitzgeraldReiterated RatingBuy$18.00Low
2/27/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$17.00Low
2/17/2018Wells Fargo & CompanySet Price TargetBuy$19.00High
1/28/2018Cantor FitzgeraldReiterated RatingBuy$17.00Low
1/18/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$17.50Medium
1/16/2018SunTrust BanksDowngradeBuy ➝ HoldHigh
1/11/2018Royal Bank of CanadaSet Price TargetBuy$19.00High
1/9/2018Maxim GroupReiterated RatingBuy$20.00Medium
1/8/2018Cantor FitzgeraldReiterated RatingBuy$17.00Low
1/4/2018CitigroupInitiated CoverageBuyLow
11/3/2017SunTrust BanksReiterated RatingBuy$16.00N/A
11/3/2017Maxim GroupReiterated RatingBuy$16.00N/A
11/3/2017Robert W. BairdBoost Price TargetOutperform$16.00 ➝ $17.00N/A
10/27/2017KeyCorpReiterated RatingHoldN/A
10/17/2017Robert W. BairdReiterated RatingBuy$16.00N/A
10/3/2017Dougherty & CoReiterated RatingBuy$15.00 ➝ $16.00Low
9/27/2017Cantor FitzgeraldReiterated RatingBuy$17.00Low
9/19/2017Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$17.00Medium
9/11/2017CowenUpgradeMarket Perform ➝ Outperform$13.00 ➝ $16.00High
8/25/2017Jefferies Financial GroupSet Price TargetBuy$17.00Low
8/15/2017Cantor FitzgeraldUpgradeNeutral ➝ Overweight$12.00Low
8/14/2017Cantor FitzgeraldReiterated RatingNeutral ➝ Buy$15.00 ➝ $17.00Low
8/7/2017CitigroupBoost Price TargetNeutral$13.00 ➝ $14.00Low
8/7/2017Morgan StanleyBoost Price TargetUnderweight$11.00 ➝ $12.00Low
8/4/2017Maxim GroupReiterated RatingBuy$16.00High
7/21/2017Piper Jaffray CompaniesReiterated RatingHold$14.00Low
6/19/2017SVB LeerinkDowngradeOutperform ➝ Market Perform$15.00 ➝ $13.00Medium
(Data available from 5/22/2017 forward)

News Sentiment Rating

0.62 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2021
  • 5 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/23/2021
  • 2 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/23/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/22/2022
  • 4 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/21/2022
  • 10 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/23/2022
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/22/2022
  • 4 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/22/2022

Current Sentiment

  • 4 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Allscripts Healthcare Solutions logo
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $16.73
Low: $16.37
High: $16.96

50 Day Range

MA: $21.01
Low: $16.73
High: $23.09

52 Week Range

Now: $16.73
Low: $13.05
High: $23.25

Volume

1,780,428 shs

Average Volume

1,619,849 shs

Market Capitalization

$1.94 billion

P/E Ratio

14.94

Dividend Yield

N/A

Beta

0.98

Frequently Asked Questions

What sell-side analysts currently cover shares of Allscripts Healthcare Solutions?

The following Wall Street sell-side analysts have issued reports on Allscripts Healthcare Solutions in the last year: Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Piper Sandler, Royal Bank of Canada, StockNews.com, SVB Leerink LLC, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for MDRX.

What is the current price target for Allscripts Healthcare Solutions?

0 Wall Street analysts have set twelve-month price targets for Allscripts Healthcare Solutions in the last year. Their average twelve-month price target is $22.00, suggesting a possible upside of 31.5%.
View the latest price targets for MDRX.

What is the current consensus analyst rating for Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MDRX will outperform the market and that investors should add to their positions of Allscripts Healthcare Solutions.
View the latest ratings for MDRX.

What other companies compete with Allscripts Healthcare Solutions?

How do I contact Allscripts Healthcare Solutions' investor relations team?

Allscripts Healthcare Solutions' physical mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker's listed phone number is (800) 334-8534 and its investor relations email address is [email protected] The official website for Allscripts Healthcare Solutions is www.allscripts.com. Learn More about contacing Allscripts Healthcare Solutions investor relations.